血液系统疾病中的分子免疫学。
Molecular Immunology in Hematological Disorders.
机构信息
Department of Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
出版信息
Int J Mol Sci. 2022 Aug 24;23(17):9584. doi: 10.3390/ijms23179584.
Abstract
This Special Issue aims to highlight the molecular mechanisms involved in the development and progression of hematologic malignancies such as leukemia, lymphoma, and myeloma [...].
摘要
本期特刊旨在强调血液系统恶性肿瘤（如白血病、淋巴瘤和骨髓瘤等）的发展和进展所涉及的分子机制。
相似文献
1
Molecular Immunology in Hematological Disorders.血液系统疾病中的分子免疫学。
Int J Mol Sci. 2022 Aug 24;23(17):9584. doi: 10.3390/ijms23179584.
2
3
B-cell maturation antigen expression across hematologic cancers: a systematic literature review.B 细胞成熟抗原在血液系统恶性肿瘤中的表达：系统文献回顾。
Blood Cancer J. 2020 Jun 30;10(6):73. doi: 10.1038/s41408-020-0337-y.
4
Familial (inherited) leukemia, lymphoma, and myeloma: an overview.家族性（遗传性）白血病、淋巴瘤和骨髓瘤：概述
Blood Cells Mol Dis. 2004 Jan-Feb;32(1):246-61. doi: 10.1016/j.bcmd.2003.10.005.
5
The Role of RNA-Binding Proteins in Hematological Malignancies.RNA 结合蛋白在血液系统恶性肿瘤中的作用。
Int J Mol Sci. 2022 Aug 23;23(17):9552. doi: 10.3390/ijms23179552.
6
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.骨髓增生异常综合征、急性髓系白血病、慢性淋巴细胞白血病和淋巴瘤的细胞遗传学及荧光原位杂交研究
Int J Hematol. 2002 Aug;76 Suppl 2:65-74. doi: 10.1007/BF03165090.
7
[Advances in the target therapy of hematological malignancies].[血液系统恶性肿瘤靶向治疗的进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jul;45(4):642-6.
8
Integrative oncogenomic analysis of microarray data in hematologic malignancies.血液系统恶性肿瘤中微阵列数据的综合肿瘤基因组分析
Methods Mol Biol. 2010;576:231-77. doi: 10.1007/978-1-59745-545-9_13.
9
Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.除毛细胞白血病外的血液系统恶性肿瘤中BRAF V600E突变缺失
Leuk Lymphoma. 2012 Dec;53(12):2498-9. doi: 10.3109/10428194.2012.695777. Epub 2012 Jul 9.
10
[p53 and hematologic malignancies].[p53与血液系统恶性肿瘤]
Pathol Biol (Paris). 1997 Dec;45(10):898-908.
本文引用的文献
1
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches.T 细胞免疫在单克隆丙种球蛋白病和多发性骨髓瘤中的作用：从免疫发病机制到新的治疗方法。
Int J Mol Sci. 2022 May 8;23(9):5242. doi: 10.3390/ijms23095242.
2
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?供者淋巴细胞输注治疗移植后病毒感染后急性神经系统受累：新型癌症免疫治疗相关 CNS 毒性的相同模式？
Int J Mol Sci. 2022 Mar 24;23(7):3553. doi: 10.3390/ijms23073553.
3
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.新型冠状病毒病和 SARS-CoV-2 疫苗接种中的凝血障碍和纤维蛋白溶解病理生理学。
Int J Mol Sci. 2022 Mar 19;23(6):3338. doi: 10.3390/ijms23063338.
4
The Impact of NLRP3 Activation on Hematopoietic Stem Cell Transplantation.NLRP3 激活对造血干细胞移植的影响。
Int J Mol Sci. 2021 Oct 31;22(21):11845. doi: 10.3390/ijms222111845.
5
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.维奈托克和达雷妥尤单抗对多发性骨髓瘤中抗体依赖性细胞介导的自然杀伤细胞细胞毒性的协同作用。
Int J Mol Sci. 2021 Oct 5;22(19):10761. doi: 10.3390/ijms221910761.
6
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.新抗原特异性 T 细胞免疫反应：NPM1 突变型急性髓系白血病的范例。
Int J Mol Sci. 2021 Aug 25;22(17):9159. doi: 10.3390/ijms22179159.
7
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.供者 UNC-93 同源物 B1 基因多态性预测亲缘外骨髓移植后的生存结局。
Genes Immun. 2021 May;22(1):35-43. doi: 10.1038/s41435-021-00122-y. Epub 2021 Feb 24.
8
Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.供体血红素加氧酶-1启动子基因多态性可预测高危患者非亲缘骨髓移植后的生存情况。
Cancers (Basel). 2020 Feb 12;12(2):424. doi: 10.3390/cancers12020424.
9
Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.异体供者异基因造血干细胞移植在中危或高危初诊完全缓解的急性髓系白血病患者中的作用。
Bone Marrow Transplant. 2019 Dec;54(12):2004-2012. doi: 10.1038/s41409-019-0571-8. Epub 2019 May 31.
10
Recipient Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.受者单核苷酸多态性预测血液系统恶性肿瘤异基因骨髓移植后复发。
Int J Mol Sci. 2019 Jan 8;20(1):214. doi: 10.3390/ijms20010214.
Zotero 插件